AGAMREE已在美国获批并上市，如果获得批准，将成为加拿大首个获授权的杜氏肌营养不良症 (DMD)治疗药物。该药是一种皮质类固醇，旨在保持疗效的同时可能具有更好耐受的副作用特征，这对于DMD患者来说是一项重大进展。DMD是一种以肌肉逐渐退化和无力为特征的遗传性疾病。

Kye Pharmaceuticals, Inc. ("Kye") announced today it has submitted a New Drug Submission (NDS) to Health Canada for the ...

Catalyst Pharmaceuticals (CPRX) reported that its sub-licensee in Canada, Kye Pharmaceuticals, has announced that Health Canada has accepted ...

Kye Jones is making headlines in the NBA for all the right reasons after his notable shift from the Los Angeles Clippers to the Dallas Mavericks. This article explores his dramatic transformations, ...

Following the news of her death, many people had their eyes on Kye Kelly, her former boyfriend. Here's what we know about ...